1. Imaging

    Comments Leave a Comment

    1-15 of 84 1 2 3 4 5 6 »
    1. Mentioned In 84 Articles

    2. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.

      ...uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma. Eur J Nucl Med Mol Imaging. 2017 Nov 07;: Authors: Li C, Zhang J, Chen S, Huang S, Wu S, Zhang L, Zhang F, Wang H To evaluat...
      Read Full Article
    3. Composite iron oxide-Prussian blue nanoparticles for magnetically guided T1-weighted magnetic resonance imaging and photothermal therapy of tumors.

      ...ning Prussian blue nanoparticles (Fe3O4@GdPB) as a novel theranostic agent for T1-weighted magnetic resonance imaging (MRI) and photothermal therapy (PTT) of tumors. These particles combine the well-described properties ...
      Read Full Article
    4. Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on (123)I-MIBG SPECT predict the outcome?

      ...blastoma: does the tumoral metabolic activity on (123)I-MIBG SPECT predict the outcome? Eur J Nucl Med Mol Imaging. 2017 Aug 14;: Authors: Rogasch JMM, Hundsdoerfer P, Furth C, Wedel F, Hofheinz F, Krüger PC, Lode...
      Read Full Article
      Mentions: Imaging MYCN MIBG
    5. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.

      ...viewed by two independent physicians for Image Defined Risk Factors (IDRF). Operation notes and corresponding imaging reports were analyzed for surgical radicality. The extent of tumor resection was classified as complet...
      Read Full Article
      Mentions: INRG Imaging MYCN
    6. Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.

      ...se I-MIBG. Organ dosimetry was estimated from the first I-MIBG posttherapy imaging and from subsequent I-MIBG imaging prior to the planned second administration. Three serial whole-body scans were performed per patient 2...
      Read Full Article
    7. 1-15 of 84 1 2 3 4 5 6 »
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Quotes about Imaging

    1. With imaging scans, disease that is starting to grow versus disease that is getting better can look very similar when you first look.
      In New biomarker assay detects neuroblastoma with greater sensitivity
    2. With imaging scans, disease that is starting to grow versus disease that is getting better can look very similar when you first look.
      In New biomarker assay detects neuroblastoma with greater sensitivity
    3. With imaging scans, disease that is starting to grow versus disease that is getting better can look very similar when you first look.
      In New Biomarker Assay Detects Neuroblastoma with Greater Sensitivity